Aplastic Anaemia Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Aplastic Anaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

Aplastic Anaemia
The First Affiliated Hospital of Soochow University224 enrolled4 locationsNCT07499284
Recruiting

Adverse Effects of ATG/ALG Therapy in Aplastic Anemia

Aplastic Anaemia
Institute of Hematology & Blood Diseases Hospital, China200 enrolled1 locationNCT07461116
Recruiting
Phase 2

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Elderly (People Aged 65 or More)Sever Aplastic AnaemiaImmunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China65 enrolled1 locationNCT07010237
Recruiting
Phase 2

Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A

Aplastic Anaemia
Peking Union Medical College Hospital40 enrolled1 locationNCT06802055
Recruiting

Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry (AAR)

Hereditary Predisposition to Haematological Malignancy (HPHM)Aplastic AnaemiaVEXAS Syndrome+1 more
Monash University1,000 enrolled37 locationsACTRN12623000461695
Recruiting
Phase 2

REscuing bone marrow function in patients with aplaStic anaEmia and bone marrow faiLure post allogEneiC Transplantation (RESELECT) Phase I/II single arm with historical control study assessing the efficacy and safety of Atorvastatin and N-Acetyl Cysteine in the treatment of Poor Graft Function post allogeneic transplantation and relapsed/refractory aplastic anaemia

One of the health conditions being studied in this trial will be Poor Graft FunctionOne of the health conditions being studied in this trial will be Aplastic Anaemia
The Royal Melbourne Hospital20 enrolled1 locationACTRN12620001339943